|
Aerocrine: UK clinical study demonstrates that asthma tests can identify non …
The Herald | HeraldOnline.com SOLNA, Sweden — Aerocrine AB (OMX Nordic Exchange: AERO) announces that a clinical trial published in The American Journal of Respiratory and Critical Care Medicine shows that FeNO-testing is an excellent tool to identify patients that don't adhere to … |
View full post on asthma – Google News